← Eichor
Study identifier: NCT06841276 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of QoLibri Medical Device on the Consequences of Chronic Pain: a Randomized Controlled Trial

Condition: Chronic Pain  ·  Sponsor: Novesia

PhaseNA
Planned participants410
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A superiority study evaluating the impact of the QoLibri Software as Medical Device on functional and psychological consequences of chronic pain in primary care patients. A prospective, cluster-randomized, wait list, controlled multicentre study with the main objective of evaluating the effectiveness of the QoLibri Digital Therapy on Quality of Life improvement in patients living with chronic pain.

This description comes directly from the study's public registry record.

Talk to the study team

Alice Corteval, PharmD  ·  +33 6 88 08 29 72  ·  a.corteval@novesia.fr

Géraldine Batot, PhD  ·  geraldine.batot@kyomed.com

Always discuss trial participation with your own doctor first.

Locations (1)

Maison de santé Nailloux / Saint-LéonNailloux, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06841276